Drug discovery

Phosphatases rise from the ashes

Read more

A new strategy for regenerating damaged tissue

Read more

Leyden Labs plans to protect against viral infections

Read more

Taming food-induced immune disorders

Read more

Developing radionuclide PARP inhibitors

Read more

The linker matters in antibody-drug conjugates

Read more

The hunt for the perfect tumour-associated antigen

Read more

Finding a link between the microbiome and disease

Read more

The role of oncolytic viruses in immuno-oncology

Read more

Investors support new antifungal agent

Read more